NDC 63629-2873

BUDEPRION SR

Bupropion Hydrochloride

BUDEPRION SR is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Bupropion Hydrochloride.

Product ID63629-2873_763ec70c-b853-4664-a648-74046636e1b2
NDC63629-2873
Product TypeHuman Prescription Drug
Proprietary NameBUDEPRION SR
Generic NameBupropion Hydrochloride
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2004-03-23
Marketing CategoryANDA / ANDA
Application NumberANDA075913
Labeler NameBryant Ranch Prepack
Substance NameBUPROPION HYDROCHLORIDE
Active Ingredient Strength150 mg/1
Pharm ClassesAminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 63629-2873-1

60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-2873-1)
Marketing Start Date2004-03-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63629-2873-1 [63629287301]

BUDEPRION SR TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA075913
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-03-23
Inactivation Date2020-01-31

NDC 63629-2873-4 [63629287304]

BUDEPRION SR TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA075913
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-03-23
Inactivation Date2020-01-31

NDC 63629-2873-3 [63629287303]

BUDEPRION SR TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA075913
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-03-23
Inactivation Date2020-01-31

NDC 63629-2873-2 [63629287302]

BUDEPRION SR TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA075913
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-03-23
Inactivation Date2020-01-31

NDC 63629-2873-5 [63629287305]

BUDEPRION SR TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA075913
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-06-02
Inactivation Date2020-01-31

NDC 63629-2873-6 [63629287306]

BUDEPRION SR TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA075913
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-06-02
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
BUPROPION HYDROCHLORIDE150 mg/1

OpenFDA Data

SPL SET ID:c3ce7349-8ef2-4e66-a7d7-24fe71d18866
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 993518
  • Pharmacological Class

    • Aminoketone [EPC]
    • Dopamine Uptake Inhibitors [MoA]
    • Increased Dopamine Activity [PE]
    • Increased Norepinephrine Activity [PE]
    • Norepinephrine Uptake Inhibitors [MoA]

    NDC Crossover Matching brand name "BUDEPRION SR" or generic name "Bupropion Hydrochloride"

    NDCBrand NameGeneric Name
    63629-2873BUDEPRION SRBUDEPRION SR
    0115-5445Bupropion HydrochlorideBUPROPION HYDROCHLORIDE
    0115-6811Bupropion HydrochlorideBUPROPION HYDROCHLORIDE
    0185-0410Bupropion HydrochlorideBupropion Hydrochloride
    0185-0415Bupropion HydrochlorideBupropion Hydrochloride
    0185-1111Bupropion HydrochlorideBupropion Hydrochloride
    0173-0135WELLBUTRINbupropion hydrochloride
    0173-0722WELLBUTRINbupropion hydrochloride
    0173-0947WELLBUTRINbupropion hydrochloride
    0173-0556ZYBANbupropion hydrochloride

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.